Bioorganic and Medicinal Chemistry Letters p. 3038 - 3041 (2016)
Update date:2022-08-05
Topics:
Yoon, Suyoung
Kim, Jong Hyun
Yoon, Ina
Kim, Changhoon
Kim, Sung-Eun
Koh, Yura
Jeong, Seung Jae
Lee, Jiyoun
Kim, Sunghoon
Lee, Jeewoo
A series of leucinol analogs were investigated as leucyl-tRNA synthetase-targeted mTORC1 inhibitors. Among them, compound 5, (S)-4-isobutyloxazolidin-2-one, showed the most potent inhibition on the mTORC1 pathway in a concentration-dependent manner. Compound 5 inhibited downstream phosphorylation of mTORC1 by blocking leucine-sensing ability of LRS, without affecting the catalytic activity of LRS. In addition, compound 5 exhibited cytotoxicity against rapamycin-resistant colon cancer cells, suggesting that LRS has the potential to serve as a novel therapeutic target.
View MoreContact:
Address:ROOM 1715, No#345 Jin Xiang Road, Pudong District
Contact:+852 83038667
Address:Room 1502, 15th Floor, SPA Centre,53-55 Lockhart Road, Wanchai, Hong Kong
Synchem Pharma Co.,Ltd(expird)
Contact:+0086-21-61984905-1
Address:Building 60,Zimian Park, LongYang industrial Area, 1515Nong,Yuandong Road Fengxian District, Shanghai ,China
Zhejiang Quzhou Jiancheng Silicone Co., Ltd.(Shanghai Jiancheng Industial and Trade Co, Ltd)
Contact:18957018777 +86-570-3888777
Address:The company production base address: Quzhou City, Zhejiang Province high-tech industrial park Nianhua Road 37
Contact:+86-021-50792271
Address:Building 24A, 300 Chuantu Road, Chuansha, Pudong new area, Shanghai, China, 201202
Doi:10.1021/jo502181a
(2014)Doi:10.1021/jm00304a015
(1969)Doi:10.1021/jo990061j
(1999)Doi:10.1007/s11172-008-0260-z
(2008)Doi:10.1016/S0277-5387(03)00478-9
(2003)Doi:10.1016/j.tetlet.2006.03.073
(2006)